基本信息
浏览量:10
职业迁徙
个人简介
Margarita Calonge, MD, PhD is a physician-scientist, full professor of Ophthalmology at the University of Valladolid (UVa) (www.uva.es) and Director of the Ocular Surface Inflammation Research Group and The Ocular Immunology & Cell Therapy Clinical Units, both at IOBA (Institute of Applied OphthalmoBiology) (www.ioba.es), Uva, Valladolid, Spain. She gained her medical degree and Ophthalmology specialty and then went on to complete her PhD in Visual Sciences at the Uva. She then completed two one-year fellowship Programs at Harvard Medical School, one at The Schepens Eye Research Institute (with Mathea Allansmith) and the second one at the Massachusetts Eye & Ear Infirmary (with Stephen Foster), both in Boston, USA.
Currently, she teaches graduate students at The Medical and Optometry Schools at Uva and postgraduate students in the IOBA PhD Inter-University Program in Visual Sciences and supervises the Ocular Immunology Clinical Fellowship program. She coordinates the Ocular Surface Disease Research Group (Recognized Research Group, Uva; Consolidated Research Unit, Government of Castile and Leon, Spain) with clinical and research interests in ocular surface inflammation (more specifically Dry Eye Disease, Ocular Allergy, and Stem Cell Deficiency), search for biomarkers of inflammation (Dry Eye Disease especificaly), and its management hrough medical therapies and stem cell-derived therapies. Additionally, she is the PI of the IOBA-Uva group belonging to CIBER-BBN (www.ciber-bbn.es). She is PI on Regional and National competitive projects uninterruptedly since 1991, and CI in 3 EU grants. She has been working with pharmaceutical companies since 1994, has been PI of several clinical trials and consults for some pharmaceutical companies. She has been heavily involved in the development of a unique environmental chamber within the Controlled Environment Laboratory (CELab), located at the IOBA building (Miguel Delibes Uva Campus) and the transferring to its spin-off, now a company, Vision R&D (www.visionrd.com) (www.visionrd.com/celab/). Consequently, she has accomplished 5 periods of 6 year each (“sexenios”) of validated research by national agencies. Recently, she got the first innovation and transference 6-year validaton period (2000-2009). She coordinates the clinical units at IOBA, where she performes her clinical activity: Ocular Immunology Unit (since 1994), Cell Therapy Unit (since 2015) and recently she has been appointed director of the IOBA OculoFacial Pain Unit.
She has delivered more than 175 invited conferences and published 180 peer-reviewed scientific publications.
研究兴趣
论文共 359 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
EXPERIMENTAL EYE RESEARCH (2024): 109854-109854
OPHTHALMOLOGY AND THERAPYno. 5 (2024): 1197-1210
The ocular surface (2024): 130-138
Heliyonno. 6 (2023): e16995-e16995
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEno. 8 (2023)
引用0浏览0引用
0
0
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEno. 8 (2023)
引用0浏览0引用
0
0
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEno. 8 (2023)
引用0浏览0引用
0
0
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEno. 8 (2023)
引用0浏览0引用
0
0
Ophthalmology and therapyno. 6 (2023): 3251-3262
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn